UK Research and Innovation MRC news Update

Pausing methotrexate doubles COVID-19 booster antibody response 28-06-2022 04:29 PM BST Interrupting the treatment of people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination doubled their antibody response. The vaccine response on off methotrexate (VROOM) trial will have implications for people on immune-supressing medicines, who are among the millions of clinically vulnerable patients advised to 'shield' during the pandemic. The results […] Help Manage Preferences Unsubscribe Contact Us Connect with us

---

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.

This service is provided to you at no charge by UK Research and Innovation.

---

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud, on behalf of: UK Research and Innovation  UK Research and Innovation, Polaris House, Swindon, SN2 1FL